ACADIA Pharmaceuticals Inc. - Financial and Strategic Analysis Review

ACADIA Pharmaceuticals Inc. - Financial and Strategic Analysis Review

Acadia Pharmaceuticals, Inc., (Acadia) engages in the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company focuses on developing a portfolio of four advanced product candidates, including Pimavanserin, which is in phase III development for Parkinson's disease psychosis; and a product candidate in phase II for chronic pain and a product candidate in phase I for glaucoma as well as other drug candidate which are in the preclinical stage of development. Acadia Pharmaceuticals, formerly known as Receptor Technologies, Inc., was founded in 1993. It is headquartered in San Diego, California and employs 143 people.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of ACADIA Pharmaceuticals Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors' weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • Overview
  • History
  • SWOT Analysis Overview
  • Overview
  • ACADIA Pharmaceuticals Inc. - Strengths
  • Focused Research and Development Activities
  • Proprietary Technologies Base
  • Focus on Diversified theraputic Segments
  • ACADIA Pharmaceuticals Inc. - Weaknesses
  • Losses from Operations
  • ACADIA Pharmaceuticals Inc. - Opportunities
  • Changing Demographics
  • Rising Healthcare Expenditure in the US
  • Pimavanserin for the treatment of Parkinson's disease in Phase III
  • ACADIA Pharmaceuticals Inc. - Threats
  • Industry Consolidation
  • Tightening of FDA's Regulatory Oversight
  • Impact of Financial Crisis
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Financial Ratios
  • Capital Market Ratios
  • Annual Ratios
  • Interim Ratios
  • Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • ACADIA Pharmaceuticals Inc., Key Facts
  • ACADIA Pharmaceuticals Inc., Key Ratios
  • ACADIA Pharmaceuticals Inc., Share Data
  • ACADIA Pharmaceuticals Inc., Key Facts
  • Major Products and Services
  • ACADIA Pharmaceuticals Inc., History
  • ACADIA Pharmaceuticals Inc., Key Employees
  • ACADIA Pharmaceuticals Inc., Key Employee Biographies
  • ACADIA Pharmaceuticals Inc., Subsidiaries
  • ACADIA Pharmaceuticals Inc., Ratios based on current share price
  • ACADIA Pharmaceuticals Inc., Annual Ratios
  • ACADIA Pharmaceuticals Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • ACADIA Pharmaceuticals Inc., Performance Chart (2004 - 2008)
  • ACADIA Pharmaceuticals Inc., Ratio Charts